Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 6(6): e21168, 2011.
Article in English | MEDLINE | ID: mdl-21695131

ABSTRACT

BACKGROUND: The process of bone resorption by osteoclasts is regulated by Cathepsin K, the lysosomal collagenase responsible for the degradation of the organic bone matrix during bone remodeling. Recently, Cathepsin K was regarded as a potential target for therapeutic intervention of osteoporosis. However, mechanisms leading to osteopenia, which is much more common in young female population and often appears to be the clinical pre-stage of idiopathic osteoporosis, still remain to be elucidated, and molecular targets need to be identified. METHODOLOGY/PRINCIPAL FINDINGS: We found, that in juvenile bone the large conductance, voltage and Ca(2+)-activated (BK) K(+) channel, which links membrane depolarization and local increases in cytosolic calcium to hyperpolarizing K(+) outward currents, is exclusively expressed in osteoclasts. In juvenile BK-deficient (BK(-/-)) female mice, plasma Cathepsin K levels were elevated two-fold when compared to wild-type littermates. This increase was linked to an osteopenic phenotype with reduced bone mineral density in long bones and enhanced porosity of trabecular meshwork in BK(-/-) vertebrae as demonstrated by high-resolution flat-panel volume computed tomography and micro-CT. However, plasma levels of sRANKL, osteoprotegerin, estrogene, Ca(2+) and triiodthyronine as well as osteoclastogenesis were not altered in BK(-/-) females. CONCLUSION/SIGNIFICANCE: Our findings suggest that the BK channel controls resorptive osteoclast activity by regulating Cathepsin K release. Targeted deletion of BK channel in mice resulted in an osteoclast-autonomous osteopenia, becoming apparent in juvenile females. Thus, the BK(-/-) mouse-line represents a new model for juvenile osteopenia, and revealed the BK channel as putative new target for therapeutic controlling of osteoclast activity.


Subject(s)
Bone Diseases, Metabolic/metabolism , Bone Diseases, Metabolic/pathology , Cathepsin K/metabolism , Gene Deletion , Large-Conductance Calcium-Activated Potassium Channels/deficiency , Large-Conductance Calcium-Activated Potassium Channels/genetics , Osteoclasts/metabolism , Animals , Bone Density/drug effects , Bone Diseases, Metabolic/diagnostic imaging , Bone Diseases, Metabolic/physiopathology , Endocrinology , Female , Mice , Osteoclasts/drug effects , Osteoclasts/pathology , RANK Ligand/chemistry , RANK Ligand/pharmacology , Solubility , Spine/diagnostic imaging , Spine/metabolism , Spine/pathology , Spine/physiopathology , Tibia/diagnostic imaging , Tibia/metabolism , Tibia/pathology , Tibia/physiopathology , X-Ray Microtomography
SELECTION OF CITATIONS
SEARCH DETAIL
...